Abstract

The UK Age Trial: screening women in their forties

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A critical appraisal of the Canadian National Breast Cancer Screening Study.
N F Boyd ... D Tritchler
Radiology | VOL. 189
N F Boyd, et. al.N F Boyd ... D Tritchler
01 Dec 1993
The role of screening mammography in the era of modern breast cancer treatment
A B Miller
Climacteric : the journal of the International Menopause Society | VOL. 21
A B MillerA B Miller
17 Jan 2018
Breast Cancer Screening
Anthony B Miller
-
Anthony B MillerAnthony B Miller
11 Oct 2012
Breast cancer: study claiming that screening women in their 40s saves lives “found the opposite,” say critics
Jacqui Wise
BMJ (Clinical research ed.) | VOL. 370
Jacqui WiseJacqui Wise
13 Aug 2020
View more papers

More From: Lancet Oncology

Paper Title
Journal
Date
Author
Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis
Kristina Jenei ... Vinay Prasad
Lancet Oncology | VOL. -
Kristina Jenei, et. al.Kristina Jenei ... Vinay Prasad
11 Jul 2024
NHS cancer services and systems—ten pressure points a UK cancer control plan needs to address
Ajay Aggarwal ... Richard Sullivan
Lancet Oncology | VOL. -
Ajay Aggarwal, et. al.Ajay Aggarwal ... Richard Sullivan
08 Jul 2024
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
Guihong Wan ... Yevgeniy R Semenov
Lancet Oncology | VOL. -
Guihong Wan, et. al.Guihong Wan ... Yevgeniy R Semenov
01 Jul 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial
Selim Corbacioglu ... Juergen Foell
Lancet Oncology | VOL. 25
Selim Corbacioglu, et. al.Selim Corbacioglu ... Juergen Foell
01 Jul 2024
View more papers